SARS-CoV-1/2广

Zhihong Wang1, Zhuangzhuang Shi2, Xiaochen Liao3

  • 1State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, Beijing, 100850, P. R. China.

概括

需要新的纳米体策略来对抗像SARS-CoV-2这样快速变异的病毒. 一个三价纳米体,B11-E8-F3,显示了针对SARS-CoV-1和SARS-CoV-2变体的宽频中和,为预防和治疗提供了潜力.